相关实验视频

Updated: May 10, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

SLC26A4 C.317C > 一种变体:功能分析和患者衍生的诱导多能干干线发展

Yijing Li¹, Tao Sun^2,3, Sang Hu⁴

¹National Center for International Research in Cell and Gene Therapy, Sino-British Research Centre for Molecular Oncology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.

Molecular genetics & genomic medicine

|April 22, 2025

概括

在SLC26A4基因的致病变体是遗传性听力损失的常见原因. 这项研究研究了一种特定的变异,揭示了它对SLC26A4蛋白表达和局部化的影响,为听力损失机制提供了洞察力.

科学领域:

遗传学是一个遗传学.
分子生物学分子生物学
耳鼻喉科耳鼻喉科耳鼻喉科

背景情况:

全球范围内,SLC26A4基因是遗传性听力损失的主要遗传原因.
在SLC26A4中误解变异很常见,但它们的功能后果通常是未知的.
对于实验室模型来研究SLC26A4变异对蛋白质功能的影响至关重要.

研究的目的:

建立一个体外系统来评估SLC26A4变体的功能影响.
调查已识别的SLC26A4变体对蛋白质表达和局部化的特定影响.

主要方法:

基因检测用于识别患者中的SLC26A4变异.
等离子体转染来评估蛋白质表达和亚细胞局部化.
从患者外周血液单核细胞 (PBMC) 中生成诱导多能干细胞 (iPSC).

主要成果:

在SLC26A4基因中鉴定出化合物异构型变体 (c.919-2A>G和c.317C>A).
这种c.317C>A变体显著降低了SLC26A4mRNA和蛋白质的表达.
这种变异导致了细胞质中的SLC26A4蛋白聚合.
成功生成并验证了患者衍生的iPSCs,保留了多能性和遗传完整性.

结论:

这项研究阐明了SLC26A4相关听力损失背后的分子机制.
这些发现凸显了c.317C>A变异对SLC26A4蛋白质功能的有害影响.
开发的体外系统和iPSC为未来对遗传性听力损失的研究提供了宝贵的平台.

关键词:

在 SLC26A4 中.c.317C > 一个 > 一个听力损失听力损失是什么这些是iPSCs.

更多相关视频

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.